Provider review
Next Vial review
Sells only microdose GLP-1s, and publishes no price for any of them.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
We may earn a commission at no extra cost to you. Affiliate partners are listed first on our rankings. How we’re funded.
No price published — a catalog entirely of microdose GLP-1s
Visit Next VialBoth obvious pricing routes return errors, so the cost cannot be learned without an intake.
Price as published
Next Vial
No price published — a catalog entirely of microdose GLP-1s
- Vs median
- Not comparable — no figure is published before intake
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- No low-dose price published
- Dispensed
- Compounded, a 503A pharmacy, not named
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
This is the most microdose-focused seller here. Both GLP-1 products are named for it, the section heading uses it, and the word appears more than a dozen times on a single page — there is no ambiguity at all about what is being sold or who it is for. Which makes the omission harder to accept rather than easier. No price appears anywhere, for either product, and both of its own pricing pages are broken. So a reader who came here specifically looking for a low-dose GLP-1 has found the seller most committed to selling one and can learn nothing whatsoever about what it costs without starting an intake and handing over their details. Four-week language appears repeatedly without attaching to any figure, which is worth confirming later, since a four-week month means thirteen charges a year rather than twelve. And no milligram is published, on a catalog where every single product is named for the size of its dose.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want a seller whose entire catalog is low-dose rather than one option among many
- You are willing to start an intake to find out the price
- You want the products named plainly for what they are
Look elsewhere if
- You are comparing on price. None is published anywhere
- You want to know the billing cadence before starting
- You want the dose stated on a product named for its dose
What it actually costs
Price as published
No price published — a catalog entirely of microdose GLP-1s
- Vs median
- Not comparable — no figure is published before intake
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- No low-dose price published
A low-dose lane may exist, but nothing public says what it costs — so the one question this page exists to answer cannot be answered before you sign up.
78 of the 548 programs here price a small dose this way. The most microdose-focused catalog anywhere here — both products are named for it and the word appears more than a dozen times on one page, so there is no ambiguity about what is sold or who it is for. Which makes the omission harder to accept rather than easier: no price appears for either product and neither of its pricing pages works, so someone who has found exactly the right seller can learn nothing about the cost.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not confirmed
- Labs
- Not required
- Pricing
- Check plan terms
What it does well
- Every GLP-1 product is a named microdose, with no ambiguity about what is sold.
- The most microdose-focused catalog found anywhere in this ranking.
- The pharmacy class is referenced and the products are clearly described.
Pharmacy, labs and oversight
Next Vial says it uses a 503A pharmacy, but does not say which one. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
1 of 4 published openly
What Next Vial publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedSays it uses a 503A pharmacy, but does not say which one.
- Not published
- A price you can read before intakeThe figure appears only after an intake quiz, so it cannot be compared before signing up.
- Not published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
This is the most microdose-focused seller in the whole ranking. Both GLP-1 products are named for it, the section heading uses it, and it appears more than a dozen times on a single page — there is no ambiguity about what is being sold or who it is for. Which makes the omission harder rather than easier to accept: no price appears anywhere, for either product, and the two obvious pricing routes both return errors. A reader who has come specifically looking for a low-dose GLP-1 has found the seller most committed to selling one and can learn nothing about what it costs without starting an intake. Four-week language appears repeatedly without attaching to any figure, which is worth confirming later since a four-week month is thirteen charges a year. And no milligram is published, on a catalog where every single product is named for the size of its dose.
The honest cons
No price is published for either product, and both pricing routes return errors.
- Four-week language appears without being attached to any figure.
- No milligram is published, on a catalog named entirely for dose size.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
Next Vial is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Also consider
Two more programs that price a small dose the way Next Vial does. Both are partners: we may earn a commission if you start care through these links.
Partner
Oak
$250–$300/mo
No low-dose price published
Partner
Wellorithm
Compounded line not published · brand pens priced
No low-dose price published
Where this sits
#369 of 548
Ordered with the companies that pay us first, and Next Vial is not one of them. A disclosed partition, not a score.
Compare all 548 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- Low dose vs full dose
- The true annual cost of a plan
- What a flat price costs at a low dose
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
HumeCare+
$199–$299/mo (gated)
- Vs median
- $24/mo above the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- No low-dose price published
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the HumeCare+ review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.